Divi's Laboratories Limited (DIVISLAB) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Total Revenue Chart for Divi's Laboratories Limited

Divi's Laboratories Limited (DIVISLAB) revenue for FY2026 was INR 105.6B, a 13.2% change from FY2025. Divi's Laboratories Limited's revenue grew from INR 3.5B in 2005 to INR 105.6B in 2026 (2940.0% over 21 years). Earnings per share grew from INR 29.13 in 2014 to INR 82.53 in 2025 (183.3%). Revenue compound annual growth rate: 5-year CAGR of 9.0%, 10-year CAGR of 10.9%, 20-year CAGR of 18.1%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.